Oxford University's COVID-19 vaccineOfficially dubbed as AZD1222, the COVID-19 vaccine has been developed by the Jenner Institute, a part of the Nuffield Department of Medicine at the University of Oxford.
The formulation is backed by by AstraZeneca PLC, a British-Swedish pharmaceutical company. The vaccine has shown positive results in the initial trial.
The vaccine candidate is safe and prompts protective immune response, according to a report in The Lancet.AstraZeneca has joined Serum Institute of India (SII), the world's largest vaccine manufacturers by number of doses produced and sold, to produce the potential vaccine in India.
Read more on livemint.com